As there are more me-too drugs crowding the marketplace, it is becoming critical to differentiate products through new formulations and delivery methods. To create these necessary new systems, leading companies are re-orienting or refining their development cycles as well as their approaches to lifecycle management.
Leaders in development, both in marketing and R&D, will benefit from this presentation by comparing their own approaches to this area of development to other companies, some of which are leading the way in organizing and resourcing this area. For example, executives can learn when in the clinical trial process companies begin to develop and market drug delivery systems.
- Functional group input on drug delivery system development by phase
- Marketing roles & responsibilities
- Marketing activities and entry point
- Key activities impact rating
- Marketing staffing levels
- Marketing budget levels
- Branding and patent protection
A key finding from the research is that 75% of companies studied employ a centralized group structure to manage the development of the new product delivery system. However, of these companies, 75% do not dedicate marketing staff to the support of the drug delivery development process.
This research was conducted under Best Practices LLC's Business Excellence Board membership research service.